This is consistent with reports of rare RUNX2 duplications in CS patients.[33] Also, this increase in ALP at earlier time points could be attributed to the lower amount of ALP present in enzyme treated CIObs ECMs compared to the ECMs secreted by CSOBs. The gene discussed is RUNX2; the disease is Cowden syndrome 1.